(Q38080920)

28 August 2017

The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium (English)

1 reference

28 August 2017

0 references

Guido Van Hal

2

0 references

Philippe Beutels

object named as

Philippe Beutels

series ordinal

4

0 references

author name string

Jessica Fraeyman

series ordinal

1

1 reference

PubMed ID

23402454

28 August 2017

Brian Godman

series ordinal

3

1 reference

28 August 2017

1 February 2013

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

28 August 2017

1 reference

28 August 2017

13

1 reference

28 August 2017

1

1 reference

28 August 2017

141-151

1 reference

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

28 August 2017

1 reference

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

21 January 2018

1 reference

Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data

21 January 2018

1 reference

Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications

21 January 2018

1 reference

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

21 January 2018

1 reference

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

21 January 2018

1 reference

The impact of reference-pricing systems in Europe: a literature review and case studies

21 January 2018

1 reference

Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs

21 January 2018

1 reference

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future

21 January 2018

1 reference

A systematic review and meta-analysis on the therapeutic equivalence of statins

21 January 2018

1 reference

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

Potential savings without compromising the quality of care

21 January 2018

1 reference

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

21 January 2018

1 reference

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

21 January 2018

1 reference

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences

21 January 2018

1 reference

Intensive statin therapy--a sea change in cardiovascular prevention

21 January 2018

1 reference

Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database

21 January 2018

1 reference

Medical evidence and health policy: a marriage of convenience? The case of proton pump inhibitors

21 January 2018

1 reference

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

21 January 2018

1 reference

21 January 2018

Using clinical evidence

1 reference

Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications

21 January 2018

1 reference

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

Generic Medicine Pricing Policies in Europe: Current Status and Impact

21 January 2018

1 reference

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

21 January 2018

1 reference

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.12.88

1 reference

28 August 2017

1 reference

PubMed ID

23402454